Ohmori T - Search Results

1

Haemophilia gene therapy-Update on new country initiatives.

Reiss UM, Mahlangu J, Ohmori T, Ozelo MC, Srivastava A, Zhang L. Reiss UM, et al. Among authors: ohmori t. Haemophilia. 2022 May;28 Suppl 4:61-67. doi: 10.1111/hae.14512. Haemophilia. 2022. PMID: 35521726 Review.

2

Immune response against serial infusion of factor VIII antigen through an implantable venous-access device system in haemophilia A mice.

Madoiwa S, Kobayashi E, Kashiwakura Y, Sakata A, Yasumoto A, Ohmori T, Mimuro J, Sakata Y. Madoiwa S, et al. Among authors: ohmori t. Haemophilia. 2012 May;18(3):e323-30. doi: 10.1111/j.1365-2516.2011.02686.x. Epub 2011 Nov 2. Haemophilia. 2012. PMID: 22044430

3

New approaches to gene and cell therapy for hemophilia.

Ohmori T, Mizukami H, Ozawa K, Sakata Y, Nishimura S. Ohmori T, et al. J Thromb Haemost. 2015 Jun;13 Suppl 1:S133-42. doi: 10.1111/jth.12926. J Thromb Haemost. 2015. PMID: 26149014 Free article. Review.

4

Advances in gene therapy for hemophilia: basis, current status, and future perspectives.

Ohmori T. Ohmori T. Int J Hematol. 2020 Jan;111(1):31-41. doi: 10.1007/s12185-018-2513-4. Epub 2018 Aug 6. Int J Hematol. 2020. PMID: 30083852 Review.

5

[Development of gene therapy for hemophilia: current states and future perspectives].

Ohmori T. Ohmori T. Rinsho Ketsueki. 2018;59(10):2238-2246. doi: 10.11406/rinketsu.59.2238. Rinsho Ketsueki. 2018. PMID: 30305531 Review. Japanese.

6

Hemophilia gene therapy-New country initiatives.

Reiss UM, Zhang L, Ohmori T. Reiss UM, et al. Among authors: ohmori t. Haemophilia. 2021 Feb;27 Suppl 3:132-141. doi: 10.1111/hae.14080. Epub 2020 Jul 7. Haemophilia. 2021. PMID: 32638467 Review.

7

Overexpression of factor VII ameliorates bleeding diathesis of factor VIII-deficient mice with inhibitors.

Yasumoto A, Madoiwa S, Kashiwakura Y, Ishiwata A, Ohmori T, Mizukami H, Ozawa K, Sakata Y, Mimuro J. Yasumoto A, et al. Among authors: ohmori t. Thromb Res. 2013 May;131(5):444-9. doi: 10.1016/j.thromres.2013.03.007. Epub 2013 Apr 6. Thromb Res. 2013. PMID: 23566532

8

Production of functional coagulation factor VIII from iPSCs using a lentiviral vector.

Kashiwakura Y, Ohmori T, Mimuro J, Madoiwa S, Inoue M, Hasegawa M, Ozawa K, Sakata Y. Kashiwakura Y, et al. Among authors: ohmori t. Haemophilia. 2014 Jan;20(1):e40-4. doi: 10.1111/hae.12311. Haemophilia. 2014. PMID: 24354485

9

CRISPR/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice.

Ohmori T, Nagao Y, Mizukami H, Sakata A, Muramatsu SI, Ozawa K, Tominaga SI, Hanazono Y, Nishimura S, Nureki O, Sakata Y. Ohmori T, et al. Sci Rep. 2017 Jun 23;7(1):4159. doi: 10.1038/s41598-017-04625-5. Sci Rep. 2017. PMID: 28646206 Free PMC article.

10

Phenotype correction of hemophilia A mice with adeno-associated virus vectors carrying the B domain-deleted canine factor VIII gene.

Ishiwata A, Mimuro J, Kashiwakura Y, Niimura M, Takano K, Ohmori T, Madoiwa S, Mizukami H, Okada T, Naka H, Yoshioka A, Ozawa K, Sakata Y. Ishiwata A, et al. Among authors: ohmori t. Thromb Res. 2006;118(5):627-35. doi: 10.1016/j.thromres.2005.11.006. Epub 2005 Dec 20. Thromb Res. 2006. PMID: 16371232

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

827 results

Search Page

Filters